Allan Jonathan's Form 4 filing
Stoke Therapeutics, Inc. (STOK) · filed Jun 18, 2026
- Accession no.
- 0001966716-26-000010
- Filed
- Jun 18, 2026
- Trade date
- Jun 16, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $43.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Allan JonathanCIK 0001966716 | Officer (GENERAL COUNSEL & CORP SEC) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Common Stock | SSaleDisposed | −1,457 | $29.95 | −$43,637.15 | 18,086 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.